The next top four genes frequently observed in cHL patients were KMT2C (20%), HAVCR2 (16.67%), TCF19 (13.33%), and DUOX2 (10%) (Table 2). The gene discussed is HAVCR2; the disease is classic Hodgkin lymphoma.